Intuitive Surgical, Inc. (NASDAQ:ISRG) is Bowen Hanes & Co. Inc.’s 8th Largest Position

Bowen Hanes & Co. Inc. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 184,930 shares of the medical equipment provider’s stock after selling 345 shares during the period. Intuitive Surgical comprises approximately 2.6% of Bowen Hanes & Co. Inc.’s holdings, making the stock its 8th largest holding. Bowen Hanes & Co. Inc.’s holdings in Intuitive Surgical were worth $96,526,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth $31,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ISRG. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,209 shares of company stock worth $11,928,127 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.7 %

Shares of NASDAQ ISRG opened at $497.30 on Thursday. The stock has a market cap of $177.13 billion, a price-to-earnings ratio of 77.58, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a 50 day simple moving average of $569.42 and a two-hundred day simple moving average of $531.60.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.